Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and demonstrated anti-tumor activity in preclinical pancreatic cancer models. The ...
David Lyon, now 31, was diagnosed with stage 4 colon cancer at 26. For March's Colorectal Cancer Awareness Month, he's urging ...
Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancerLicensing deal reflects ...
Nick Leeson was diagnosed with colon cancer in prison and had surgery and treatment. He says self-pity was pointless despite ...
Survival rates for people with cholangiocarcinoma, a silent but deadly form of cancer originating in the bile ducts, are dismal and a new approach is needed, argues a panel of leading experts ...
The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid ...
Individuals share their journeys battling cancer and their experiences with groundbreaking immunotherapy treatments.
A phase 2 trial showed that combining targeted radiotherapy with PD-1 blockade and a bevacizumab biosimilar can elicit ...
A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...
At CrossFit Mecklenburg, members sweat over three words on the wall: “Movement is medicine.” On March 7, working out gives ...
The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...
Morning Overview on MSN
Simple blood test could soon spot deadly gallbladder cancer early
Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results